Kearns-Sayre syndrome (KSS) is a subtype of chronic progressive external ophthalmoplegia (CPEO). KSS is defined by the following triad: Onset before the age of 20, CPEO, and pigmentary retinopathy. Affected individuals have at least 1 of the following conditions: complete heart block, cerebrospinal fluid protein greater than 100mg/dL, cerebellar ataxia, short stature, deafness, dementia, and endocrine abnormalities. This activity describes the pathophysiology, etiology, presentation, and management of Kearns-Sayre syndrome and highlights the role of the interprofessional team in providing high-quality care to affected patients.

**Objectives:**
- Review the etiology of Kearns-Sayre syndrome.
- Describe the presentation of Kearns-Sayre syndrome.
- Summarize the treatment options for Kearns-Sayre syndrome.
- Explain the importance of enhancing care coordination amongst interprofessional team members to improve outcomes for patients affected by Kearns-Sayre syndrome.